Emerging therapies for the patient with refractory nausea and vomiting

Emerging therapies for the patient with refractory nausea and vomiting

Patients with refractory nausea and vomiting are among the most challenging for gastroenterologists to manage. The challenge is not only in the clinic – these patients are frequently admitted to hospital, often resulting, in high healthcare costs.

The existing literature and classification process does not often translate to clinical utility in terms of defining management pathways. Emerging data on endoscopic and neuromodulatory therapies show promise and a critical next step is understanding where in the clinical pathways these fit.

Programme

1.           50 years of physiological research – what progress have we seen?
2.           What does the classification tell us? (Rome IV and other consensus documents)
3.           The impact of refractory nausea and vomiting
4.           Gastric Electrical Stimulation – who are we helping (published data)
5.           GPOEM – who are we helping (published data)